ArticleRSC advances2023

Novel targeted pH-responsive drug delivery systems based on PEGMA-modified bimetallic Prussian blue analogs for breast cancer chemotherapy.

Qiang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.